Related Experiment Video
Updated: May 26, 2025

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
Published on: May 22, 2018
34βE12 is the Most Reliable Marker for Keratin-Derived Cutaneous Amyloid: A Comparative Study
Maged Daruish1,2, Ghada Al-Sharbatee3, Corrado D'Arrigo2
1Department of Cellular Pathology, Dorset County Hospital NHS Foundation Trust, Dorchester, United Kingdom.
Congo red staining for amyloidosis can be unreliable. This study compared Congo red to cytokeratin markers, finding potential for improved diagnostic accuracy in cutaneous amyloidosis.
Area of Science:
- Dermatopathology
- Histopathology
- Biomarker Research
Background:
- Congo red (CR) is the standard stain for detecting amyloid deposition in pathology.
- CR staining exhibits variable sensitivity, leading to potential false-negative results in amyloidosis diagnosis.
Purpose of the Study:
- To compare the staining intensity of Congo red with commercially available cytokeratin immunohistochemical markers.
- To evaluate diagnostic accuracy for primary cutaneous amyloidosis originating from keratin filaments.
Main Methods:
- Retrospective analysis of primary cutaneous amyloidosis cases.
- Comparative staining intensity assessment of Congo red versus cytokeratin markers.
- Immunohistochemical techniques utilized for marker evaluation.
Main Results:
- Cytokeratin markers demonstrated distinct staining patterns compared to Congo red.
- Variability in Congo red staining intensity was observed.
- Preliminary findings suggest cytokeratin markers may offer enhanced sensitivity.
Conclusions:
- Congo red's limitations in sensitivity necessitate exploration of alternative diagnostic tools.
- Cytokeratin immunohistochemical markers show promise as adjuncts or replacements for CR in specific cutaneous amyloidosis cases.
- Further research is warranted to validate these findings and establish optimal diagnostic protocols.
More Related Videos
06:19Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model
Published on: October 20, 2023
06:34A Tailored HPLC Purification Protocol That Yields High-purity Amyloid Beta 42 and Amyloid Beta 40 Peptides, Capable of Oligomer Formation
Published on: March 27, 2017